![Michael Secora](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Secora
Finanzdirektor/CFO bei
Entos, Inc.
Profil
Derzeit ist Michael Secora Finanzvorstand von Recursion Pharmaceuticals, Inc. und Portfolio Manager bei Laurion Capital Management LP. Dr. Secora erwarb einen Abschluss an der Princeton University und einen Bachelor-Abschluss am Massachusetts Institute of Technology.
Aktive Positionen von Michael Secora
| Unternehmen | Position | Beginn |
|---|---|---|
Entos, Inc.
 Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Finanzdirektor/CFO | 01.01.2025 |
Ehemalige bekannte Positionen von Michael Secora
| Unternehmen | Position | Ende |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 20.11.2024 |
Laurion Capital Management LP
 Laurion Capital Management LP Investment ManagersFinance LCM seeks to generate attractive returns on capital with controlled exposure to market direction. Their fund aims to profit from a global multi-disciplinary approach that uses a variety of trading strategies, including, among others, volatility trading strategies, model-based strategies, relative value strategies, event-driven strategies, and discretionary and macro-style trading strategies. It invests in a broad array of securities and derivatives under a range of different market scenarios, making use of these and other strategies. | Portfolio Manager-Aktien | 01.01.2020 |
Ausbildung von Michael Secora
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laurion Capital Management LP
Laurion Capital Management LP Investment ManagersFinance LCM seeks to generate attractive returns on capital with controlled exposure to market direction. Their fund aims to profit from a global multi-disciplinary approach that uses a variety of trading strategies, including, among others, volatility trading strategies, model-based strategies, relative value strategies, event-driven strategies, and discretionary and macro-style trading strategies. It invests in a broad array of securities and derivatives under a range of different market scenarios, making use of these and other strategies. | Finance |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
